UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Nature communications, 2021-06, Vol.12 (1), p.3528-13, Article 3528

2021

Volltextzugriff (PDF)

Inflammatory breast cancer biology: the tumour microenvironment is key

Nature reviews. Cancer, 2018-08, Vol.18 (8), p.485-499

2018

Volltextzugriff (PDF)

Role of epidermal growth factor receptor in breast cancer

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.331-345

2012

Volltextzugriff (PDF)

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540

2013

Volltextzugriff (PDF)

Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer

Molecular oncology, 2015-06, Vol.9 (6), p.1155-1168

2015

Volltextzugriff (PDF)

JNK Signaling in Stem Cell Self-Renewal and Differentiation

International journal of molecular sciences, 2020-04, Vol.21 (7), p.2613

2020

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

The New England journal of medicine, 2022-07, Vol.387 (1), p.9-20

2022

Volltextzugriff (PDF)

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review

JAMA oncology, 2017-09, Vol.3 (9), p.1266

2017

Volltextzugriff (PDF)

Body composition and breast cancer risk and treatment: mechanisms and impact

Breast cancer research and treatment, 2021-04, Vol.186 (2), p.273-283

2021

Volltextzugriff (PDF)

Optogenetic relaxation of actomyosin contractility uncovers mechanistic roles of cortical tension during cytokinesis

Nature communications, 2021-12, Vol.12 (1), p.7145-7145, Article 7145

2021

Volltextzugriff (PDF)

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

PloS one, 2020-04, Vol.15 (4), p.e0231953

2020

Volltextzugriff (PDF)

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Journal of clinical oncology, 2012-02, Vol.30 (6), p.593-599

2012

Volltextzugriff (PDF)

Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

Clinical cancer research, 2013-09, Vol.19 (17), p.4685-4696

2013

Volltextzugriff (PDF)

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2689-2701

2018

Volltextzugriff (PDF)

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

PloS one, 2015-07, Vol.10 (7), p.e0132710-e0132710

2015

Volltextzugriff (PDF)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Breast cancer research : BCR, 2011-06, Vol.13 (3), p.R67-R67, Article R67

2011

Volltextzugriff (PDF)

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

PloS one, 2020, Vol.15 (3), p.e0229903-e0229903

2020

Volltextzugriff (PDF)

Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (46), p.18707-18712

2012

Volltextzugriff (PDF)

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

PloS one, 2021-04, Vol.16 (4), p.e0250057-e0250057

2021

Volltextzugriff (PDF)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Oncoimmunology, 2021-01, Vol.10 (1), p.1929724-1929724

2021

Volltextzugriff (PDF)

Targeting EGFR in Triple Negative Breast Cancer

Journal of Cancer, 2011-01, Vol.2 (1), p.324-328

2011

Volltextzugriff (PDF)

The immunogram of inflammatory breast cancer

Cancer treatment reviews, 2023-09, Vol.119, p.102598-102598, Article 102598

2023

Volltextzugriff (PDF)

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer

Expert opinion on investigational drugs, 2017-04, Vol.26 (4), p.463-479

2017

Volltextzugriff (PDF)

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2753-2762

2015

Volltextzugriff (PDF)

Advances in targets in inflammatory breast cancer

International review of cell and molecular biology, 2024, Vol.384, p.125-152

2024

Volltextzugriff (PDF)

1 – 25 von 1.433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.211)
Mit Volltextzugriff
(1.266)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.386)
Japanisch
(381)
Koreanisch
(3)
Deutsch
(2)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(140)
Journal Of Clinical Oncology
(80)
Breast Cancer Research And Treatment
(29)
Journal Of Cancer
(28)
Plos One
(26)
Biochemical And Biophysical Research Communications
(25)
Developmental Biology
(23)
Molecular Cancer Therapeutics
(23)
Blood
(22)
Cancer
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Inflammatory breast cancer biology: the tumour microenvironment is key

Role of epidermal growth factor receptor in breast cancer

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer

JNK Signaling in Stem Cell Self-Renewal and Differentiation

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review

Body composition and breast cancer risk and treatment: mechanisms and impact

Optogenetic relaxation of actomyosin contractility uncovers mechanistic roles of cortical tension during cytokinesis

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Targeting EGFR in Triple Negative Breast Cancer

The immunogram of inflammatory breast cancer

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

Advances in targets in inflammatory breast cancer

Suchergebnisse filtern